FGFBP1

Summary

FGFBP1 (fibroblast growth factor binding protein 1, HGNC:19695) is a protein-coding gene on chromosome 4p15.32, encoding Fibroblast growth factor-binding protein 1 (Q14512). Acts as a carrier protein that release fibroblast-binding factors (FGFs) from the extracellular matrix (EM) storage and thus enhance the mitogenic activity of FGFs.

This gene encodes a secreted fibroblast growth factor carrier protein. The encoded protein plays a critical role in cell proliferation, differentiation and migration by binding to fibroblast growth factors and potentiating their biological effects on target cells. The encoded protein may also play a role in tumor growth as an angiogenic switch molecule, and expression of this gene has been associated with several types of cancer including pancreatic and colorectal adenocarcinoma. A pseudogene of this gene is also located on the short arm of chromosome 4.

Source: NCBI Gene 9982 — RefSeq curated summary.

At a glance

• GWAS associations: 1
• Clinical variants (ClinVar): 42 total
• MANE Select transcript: NM_005130

Identifiers

Gene identifiers

Field	Value
HGNC ID	HGNC:19695
Approved symbol	FGFBP1
Name	fibroblast growth factor binding protein 1
Location	4p15.32
Locus type	gene with protein product
Status	Approved
Aliases	HBP17, FGFBP
Ensembl gene	ENSG00000137440
Ensembl biotype	protein_coding
OMIM	607737
Entrez	9982

Gene structure

Transcript identifiers

Ensembl transcripts: 4 — 4 protein_coding

ENST00000382333, ENST00000888688, ENST00000888689, ENST00000955057

RefSeq mRNA: 1 — MANE Select: NM_005130 NM_005130

CCDS: CCDS3418

Canonical transcript exons

ENST00000382333 — 3 exons

Exon	Start	End
ENSE00001491748	15935577	15936652
ENSE00001491752	15938251	15938471
ENSE00001491754	15938687	15938740

Expression profiles

Bgee: expression breadth ubiquitous, 171 present calls, max score 98.66.

FANTOM5 (CAGE): breadth broad, TPM avg 18.0681 / max 2528.5457, expressed in 241 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter ID	TPM avg	Samples expressed
51470	16.6681	221
51471	1.4000	138

Top tissues by expression

282 total, by Bgee expression score (0-100, higher = more expressed):

Tissue	Anatomy ID	Expression score	Quality
pharyngeal mucosa	UBERON:0000355	98.66	gold quality
tongue squamous epithelium	UBERON:0006919	98.57	gold quality
gingiva	UBERON:0001828	98.48	gold quality
gingival epithelium	UBERON:0001949	98.37	gold quality
esophagus mucosa	UBERON:0002469	98.14	gold quality
cervix squamous epithelium	UBERON:0006922	98.10	gold quality
oral cavity	UBERON:0000167	98.02	gold quality
cervix epithelium	UBERON:0004801	97.47	gold quality
squamous epithelium	UBERON:0006914	97.28	gold quality
lower esophagus mucosa	UBERON:0035834	96.76	gold quality
esophagus squamous epithelium	UBERON:0006920	96.36	gold quality
epithelium of esophagus	UBERON:0001976	95.97	gold quality
mucosa of transverse colon	UBERON:0004991	95.41	gold quality
penis	UBERON:0000989	95.37	gold quality
mammalian vulva	UBERON:0000997	93.32	gold quality
skin of abdomen	UBERON:0001416	92.26	gold quality
zone of skin	UBERON:0000014	89.90	gold quality
skin of leg	UBERON:0001511	89.76	gold quality
body of tongue	UBERON:0011876	89.65	gold quality
upper leg skin	UBERON:0004262	88.23	gold quality
ileal mucosa	UBERON:0000331	88.05	gold quality
vagina	UBERON:0000996	87.22	gold quality
olfactory segment of nasal mucosa	UBERON:0005386	84.57	gold quality
islet of Langerhans	UBERON:0000006	84.47	gold quality
rectum	UBERON:0001052	83.55	gold quality
mucosa of sigmoid colon	UBERON:0004993	82.86	gold quality
colonic mucosa	UBERON:0000317	82.73	gold quality
skin of hip	UBERON:0001554	80.86	gold quality
tongue	UBERON:0001723	80.72	gold quality
trachea	UBERON:0003126	80.35	gold quality

Single-cell (SCXA)

Detected in 4 experiment(s), a significant marker in 3.

Experiment	Marker?	Max mean expression
E-HCAD-1	yes	243.31
E-MTAB-8142	yes	116.76
E-MTAB-10596	no	1737.90
E-ANND-3	no	0.00

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): AP1, CEBPB, CEBPG, CREB3L1, ETS1, FOS, HIC1, JUN, JUND, KLF5, MYC, RARA, SP1, USF1

miRNA regulators (miRDB)

16 targeting FGFBP1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNA	Max score	Avg score	miRNA target_count
HSA-MIR-548P	99.98	72.25	3784
HSA-MIR-10527-5P	99.91	72.28	3754
HSA-MIR-556-3P	99.74	68.75	1203
HSA-MIR-6832-5P	99.58	64.82	1132
HSA-MIR-4762-3P	99.43	69.72	2363
HSA-MIR-149-5P	99.25	67.16	1315
HSA-MIR-4291	99.20	68.88	2969
HSA-MIR-7109-5P	99.18	66.13	1057
HSA-MIR-548L	99.06	70.90	2560
HSA-MIR-922	99.02	67.23	1838
HSA-MIR-6512-5P	98.76	69.29	1195
HSA-MIR-6887-5P	98.56	68.49	1295
HSA-MIR-6795-5P	98.52	68.51	1277
HSA-MIR-7703	97.64	67.00	965
HSA-MIR-6736-3P	96.98	65.22	1342
HSA-MIR-500B-3P	96.49	65.40	1087

Literature-anchored findings (GeneRIF, showing 16)

• Upregulation of FGF-BP expression after injury stimulates FGF activity at the wound site, thus enhancing the process of epithelial repair. (PMID:15806171)
• the FGF interaction domain is contained in the C terminus of FGF-BP1 (PMID:16257968)
• FGF-BP can be rate-limiting for tumor growth and serves as an angiogenic switch molecule, and that it represents an increasingly promising target molecule in anti-tumor therapy[review] (PMID:16324873)
• The upregulation of FGF-BP by regenerating renal tubular epithelial cells may provide a mechanism by which the regenerative and angiogenic activity of FGF-2 in renal capillaries can be modulated in children with HIV-HUS and other renal disease. (PMID:16352855)
• KLF5 promotes breast cell survival partially through fibroblast growth factor-binding protein 1-pERK-mediated dual specificity MKP-1 protein phosphorylation and stabilization. (PMID:19411256)
• KLF5 may promote breast cancer cell proliferation at least partially through directly activating the FGF-BP mRNA transcription. (PMID:19668233)
• Sequence variation in FGFBP1 may contribute to variation in bone mineral density, possibly influencing osteoporosis risk. (PMID:20450993)
• FGFBP1 associates with hypertension and that systematic analysis of signaling pathways can identify previously undescribed genetic associations. (PMID:21436287)
• overexpression of FGFBP1 or loss of WISP-2 expression is closely related to the metastasis, invasion and poor prognosis of gallbladder cancer. (PMID:23592278)
• Up-regulated Sox12 induced by FoxQ1 promotes hepatocellular carcinoma invasion and metastasis by transactivating Twist1 and FGFBP1 expression. (PMID:25704764)
• These findings indicate that the miR-146a-CREB3L1-FGFBP1 signaling axis plays an important role in the regulation of angiogenesis in human umbilical vein endothelial cells. (PMID:27121396)
• Genetic polymorphism in the human FGFBP1 gene was associated with higher gene expression and an increased risk of familial Hypertension. (PMID:29158353)
• The Expression and Prognostic Value of FGF2, FGFR3, and FGFBP1 in Esophageal Squamous Cell Carcinoma. (PMID:33381388)
• FGFBP1-mediated crosstalk between fibroblasts and pancreatic cancer cells via FGF22/FGFR2 promotes invasion and metastasis of pancreatic cancer. (PMID:34117747)
• Poly-L-arginine promotes asthma angiogenesis through induction of FGFBP1 in airway epithelial cells via activation of the mTORC1-STAT3 pathway. (PMID:34341336)
• HAI-1 is required for the novel role of FGFBP1 in maintenance of cell morphology and F-actin rearrangement in human keratinocytes. (PMID:37076641)

Cross-species orthologs

2 orthologs

Organism	Symbol	Gene ID
mus_musculus	Fgfbp1	ENSMUSG00000048373
rattus_norvegicus	Fgfbp1	ENSRNOG00000003095

Paralogs (2): FGFBP2 (ENSG00000137441), FGFBP3 (ENSG00000174721)

Protein

Protein identifiers

Fibroblast growth factor-binding protein 1 — Q14512 (reviewed: Q14512)

Alternative names: 17 kDa heparin-binding growth factor-binding protein

All UniProt accessions (1): Q14512

UniProt curated annotations — full annotation on UniProt →

Function. Acts as a carrier protein that release fibroblast-binding factors (FGFs) from the extracellular matrix (EM) storage and thus enhance the mitogenic activity of FGFs. Enhances FGF2 signaling during tissue repair, angiogenesis and in tumor growth.

Subunit / interactions. Found in a complex with FGFBP1, FGF1 and FGF2. Interacts with FGF1, FGF2, FGF7, FGF10, FGF22 and HSPG2.

Subcellular location. Secreted. Extracellular space. Cell membrane.

Tissue specificity. Expressed in the suprabasal region of the epidermis, in hair follicles, the basement membrane at the dermo-epidermal junction (occasionally extending into the basement membrane of dermal blood vessels), wounded skin and several invasive squamous cell carcinomas (at protein level). Expressed in normal and wounded skin and various squamous cell carcinomas.

Induction. Up-regulated in epithelial cells after skin injury. Keratinocyte mitogens.

Miscellaneous. Expression is significantly up-regulated in carcinogen-induced skin tumors, various squamous cell carcinomas, some colon cancer cell lines and tumors.

Similarity. Belongs to the fibroblast growth factor-binding protein family.

RefSeq proteins (1): NP_005121* (*=MANE)

Domains & families (InterPro)

ID	Name	Type
IPR010510	FGF1-bd	Family

Pfam: PF06473

UniProt features (12 total): disulfide bond 5, region of interest 2, signal peptide 1, chain 1, mutagenesis site 1, compositionally biased region 1, glycosylation site 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

Model	pLDDT	Fraction very-high
AF-Q14512-F1	74.06	0.44

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Disulfide bonds (5): 214–222, 68–85, 94–127, 103–139, 197–234

Glycosylation sites (1): 169

Mutagenesis-validated functional residues (1):

Position	Phenotype
214	strongly reduces interaction with fgf2.

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

ID	Pathway
R-HSA-190377	FGFR2b ligand binding and activation

MSigDB gene sets: 165 (showing top): GSE45365_NK_CELL_VS_CD8_TCELL_UP, MODULE_92, GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS, BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN, JAEGER_METASTASIS_DN, REACTOME_SIGNALING_BY_FGFR, GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP, GOBP_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS, GOCC_CELL_SURFACE, SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN, GOBP_CELL_CELL_SIGNALING, GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION, BILD_HRAS_ONCOGENIC_SIGNATURE, MARTINEZ_RB1_TARGETS_UP, GOBP_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION

GO Biological Process (9): signal transduction (GO:0007165), cell-cell signaling (GO:0007267), negative regulation of cell population proliferation (GO:0008285), fibroblast growth factor receptor signaling pathway (GO:0008543), positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743), myoblast proliferation (GO:0051450), positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050), positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589), positive regulation of myoblast proliferation (GO:2000288)

GO Molecular Function (4): heparin binding (GO:0008201), fibroblast growth factor binding (GO:0017134), growth factor binding (GO:0019838), protein binding (GO:0005515)

GO Cellular Component (5): extracellular region (GO:0005576), obsolete extracellular space (GO:0005615), plasma membrane (GO:0005886), cell surface (GO:0009986), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-1 pathways:

Category	Pathways
FGFR2 ligand binding and activation	1

GO top-level categories

Rollup of top GO terms by namespace:

Category	Terms
cellular anatomical structure	3
cell communication	2
signaling	2
cell population proliferation	2
cellular process	1
regulation of cellular process	1
cellular response to stimulus	1
regulation of cell population proliferation	1
negative regulation of cellular process	1
cell surface receptor protein tyrosine kinase signaling pathway	1
cellular response to fibroblast growth factor stimulus	1
fibroblast growth factor receptor signaling pathway	1
positive regulation of signal transduction	1
regulation of fibroblast growth factor receptor signaling pathway	1
cell migration involved in sprouting angiogenesis	1
positive regulation of blood vessel endothelial cell migration	1
regulation of cell migration involved in sprouting angiogenesis	1
positive regulation of endothelial cell proliferation	1
blood vessel endothelial cell proliferation involved in sprouting angiogenesis	1
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis	1
positive regulation of cell population proliferation	1
myoblast proliferation	1
regulation of myoblast proliferation	1
glycosaminoglycan binding	1
sulfur compound binding	1
growth factor binding	1
protein binding	1
binding	1
membrane	1
cell periphery	1

Protein interactions and networks

STRING

912 interactions, top by confidence (×1000):

Protein A	Protein B	Partner UniProt	Score
FGFBP1	FGF1	P05230	991
FGFBP1	FGF7	P21781	980
FGFBP1	FGF2	P09038	977
FGFBP1	FGF22	Q9HCT0	976
FGFBP1	FGF10	O15520	974
FGFBP1	FGF13	Q92913	952
FGFBP1	FGF18	O76093	946
FGFBP1	FGF20	Q9NP95	945
FGFBP1	FGF5	P12034	945
FGFBP1	FGF16	O43320	944
FGFBP1	FGF6	P10767	942
FGFBP1	FGF17	O60258	942
FGFBP1	FGF9	P31371	941
FGFBP1	FGF3	P11487	940
FGFBP1	FGF4	P08620	938

IntAct

42 interactions, top by confidence:

A	B	Type	Score
FGFBP1	FGF2	psi-mi:“MI:0407”(direct interaction)	0.620
ASPH	FGFBP1	psi-mi:“MI:0915”(physical association)	0.560
AKT1	FGFBP1	psi-mi:“MI:2364”(proximity)	0.470
FGFBP1	AKT1	psi-mi:“MI:0915”(physical association)	0.470
FGFBP1	H1-0	psi-mi:“MI:0915”(physical association)	0.400
	POLR3A	psi-mi:“MI:0914”(association)	0.350
	ENO1	psi-mi:“MI:0914”(association)	0.350
	DDX3X	psi-mi:“MI:0914”(association)	0.350
	PES1	psi-mi:“MI:0914”(association)	0.350
	HNRNPDL	psi-mi:“MI:0914”(association)	0.350
	IGF2BP3	psi-mi:“MI:0914”(association)	0.350
	GTPBP10	psi-mi:“MI:0914”(association)	0.350
FGFBP1	ZNF724	psi-mi:“MI:0914”(association)	0.350
	ESYT2	psi-mi:“MI:0914”(association)	0.350
FGFBP1		psi-mi:“MI:0914”(association)	0.350
	EIF3F	psi-mi:“MI:0914”(association)	0.350
SULF2	IGLL5	psi-mi:“MI:0914”(association)	0.350
FBXW7	FGFBP1	psi-mi:“MI:2364”(proximity)	0.270

BioGRID (257): FGFBP1 (Affinity Capture-MS), ASPH (Two-hybrid), FGFBP1 (Affinity Capture-Western), FGFBP1 (Proximity Label-MS), HSPG2 (Two-hybrid), HSPG2 (Affinity Capture-Western), YTHDC2 (Affinity Capture-MS), NOC3L (Affinity Capture-MS), NOL8 (Affinity Capture-MS), PRPF4B (Affinity Capture-MS), URB1 (Affinity Capture-MS), NOC4L (Affinity Capture-MS), KNOP1 (Affinity Capture-MS), UTP3 (Affinity Capture-MS), RRP8 (Affinity Capture-MS)

ESM2 similar proteins: A0A2R8QHQ6, A0A8M9PDM1, A6PWV3, A6QL94, D3Z690, F5HC71, O02699, O12980, O77515, P04401, P05402, P0DJF3, P0DP43, P12401, P17150, P18917, P19159, P20826, P21583, P21702, P33579, P33580, P46685, P52173, P79169, Q08125, Q14512, Q28586, Q29030, Q4R6V5, Q5VZ72, Q60440, Q62575, Q6AY06, Q6P7N7, Q920I0, Q95J76, Q95MD2, Q95N18, Q9CQ58

Diamond homologs: O70514, Q14512, Q9MZ06, Q9QY10

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

42 variants total. Per-class counts are floors (≥ shown; pagination cap):

Classification	Count (floor)
Pathogenic	0
Likely pathogenic	0
Uncertain significance	34
Likely benign	7
Benign	1

Top pathogenic / likely-pathogenic (0)

SpliceAI

409 predictions. Top by Δscore:

Variant	Effect	Δscore
4:15936649:TCAC:T	acceptor_gain	1.0000
4:15936650:CAC:C	acceptor_gain	1.0000
4:15936650:CACC:C	acceptor_gain	1.0000
4:15936652:CCTGT:C	acceptor_loss	1.0000
4:15936653:C:CC	acceptor_gain	1.0000
4:15936653:C:CG	acceptor_loss	1.0000
4:15936654:T:A	acceptor_loss	1.0000
4:15936657:T:C	acceptor_gain	1.0000
4:15936648:TTCAC:T	acceptor_gain	0.9900
4:15936651:AC:A	acceptor_gain	0.9900
4:15936652:CC:C	acceptor_gain	0.9900
4:15936656:T:TC	acceptor_gain	0.9900
4:15936661:C:CT	acceptor_gain	0.9900
4:15936656:T:C	acceptor_gain	0.9800
4:15936662:A:T	acceptor_gain	0.9800
4:15936657:T:TC	acceptor_gain	0.9700
4:15936655:G:GC	acceptor_gain	0.9600
4:15936592:A:T	acceptor_gain	0.9500
4:15936591:CAG:C	acceptor_gain	0.9100
4:15938245:TCTTA:T	donor_loss	0.8800
4:15938246:CTTAC:C	donor_loss	0.8800
4:15938247:TTA:T	donor_loss	0.8800
4:15938248:TA:T	donor_loss	0.8800
4:15938249:ACCT:A	donor_loss	0.8800
4:15938250:C:A	donor_loss	0.8800
4:15938681:TTTTA:T	donor_loss	0.8600
4:15938682:TTTAC:T	donor_loss	0.8600
4:15938683:TTACC:T	donor_loss	0.8600
4:15938684:TA:T	donor_loss	0.8600
4:15938685:ACC:A	donor_loss	0.8600

AlphaMissense

1540 scored. Top likely-pathogenic:

Variant	Protein change	am_pathogenicity
4:15936294:C:A	W113C	0.997
4:15936294:C:G	W113C	0.997
4:15936346:A:C	F96C	0.996
4:15936423:C:A	W70C	0.996
4:15936423:C:G	W70C	0.996
4:15936430:C:G	C68S	0.995
4:15936431:A:T	C68S	0.995
4:15936217:C:G	C139S	0.994
4:15936218:A:T	C139S	0.994
4:15936253:C:G	C127S	0.994
4:15936254:A:T	C127S	0.994
4:15936379:C:G	C85S	0.994
4:15936380:A:T	C85S	0.994
4:15936341:C:A	G98C	0.992
4:15936325:C:G	C103S	0.991
4:15936326:A:T	C103S	0.991
4:15936352:C:G	C94S	0.991
4:15936353:A:T	C94S	0.991
4:15936454:A:C	F60C	0.991
4:15936345:A:C	F96L	0.989
4:15936345:A:T	F96L	0.989
4:15936346:A:G	F96S	0.989
4:15936347:A:G	F96L	0.989
4:15936429:G:C	C68W	0.989
4:15936380:A:G	C85R	0.988
4:15936218:A:G	C139R	0.987
4:15936352:C:T	C94Y	0.987
4:15936425:A:G	W70R	0.987
4:15936425:A:T	W70R	0.987
4:15936254:A:G	C127R	0.986

dbSNP variants (sampled 300 via entrez): RS1000377112 (4:15939363 T>G), RS1000895275 (4:15937499 G>A), RS1000968673 (4:15937260 G>A,C), RS1001447723 (4:15935277 C>T), RS1001663628 (4:15940377 G>A), RS1002356079 (4:15937222 A>G), RS1002431269 (4:15936920 C>T), RS1002746902 (4:15935815 C>G,T), RS1003211312 (4:15937713 A>C), RS1003796482 (4:15940518 C>T), RS1004100744 (4:15940695 C>A), RS1004446997 (4:15935258 G>A,T), RS1004908788 (4:15938689 G>A,C), RS1004972729 (4:15935490 T>G), RS1005501553 (4:15940079 G>T)

Disease associations

OMIM: gene MIM:607737 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

Study	Trait	p-value
GCST90026413_11	Severe insulin-deficient type 2 diabetes	7.000000e-07

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

PharmGKB variants

2 variants.

Variant	Genes	Level	Score	#Clin annots	Drugs
rs2245964	FGFBP1		0.00	0
rs16892645	FGFBP1		0.00	0

CTD chemical–gene interactions

49 total (human), top 30 by PubMed support.

Chemical	Actions (top 5)	PubMed papers
sodium arsenite	decreases expression, increases expression	4
Tobacco Smoke Pollution	affects expression, decreases expression, increases expression	3
Cadmium Chloride	increases expression, decreases expression	3
bisphenol A	decreases expression	2
perfluorooctanoic acid	decreases expression, increases expression	2
chloropicrin	decreases expression	2
dimethylarsinous acid	decreases expression	2
Air Pollutants	increases expression, decreases expression, increases abundance	2
bisphenol F	decreases expression	1
propionaldehyde	increases expression	1
lead acetate	decreases expression	1
ethyl-p-hydroxybenzoate	increases expression	1
methylparaben	decreases expression	1
sulforaphane	decreases expression	1
butyraldehyde	increases expression	1
cupric chloride	decreases expression	1
perfluorodecanoic acid	decreases expression	1
epigallocatechin gallate	increases expression	1
pentanal	increases expression	1
seocalcitol	decreases expression	1
CGP 52608	affects binding, increases reaction	1
monomethylarsonous acid	decreases expression	1
abrine	decreases expression	1
2,2’,4,4’-tetrabromodiphenyl ether	increases expression	1
bisphenol S	decreases expression	1
fatostatin	decreases expression	1
(+)-JQ1 compound	decreases expression	1
Zoledronic Acid	increases expression	1
Aldehydes	increases expression	1
Arsenic	affects methylation	1

Cellosaurus cell lines

3 cell lines: 3 embryonic stem cell

First 10 cell lines (id-ordered, not curated):

Cellosaurus	Name	Category	Sex
CVCL_A1T8	SEES3-1V human FGFBP1, clone1	Embryonic stem cell	Male
CVCL_A1T9	SEES3-1V human FGFBP1, clone2	Embryonic stem cell	Male
CVCL_A1U0	SEES3-1V human FGFBP1, clone3	Embryonic stem cell	Male

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.